A729 - ABACAVIR + LAMIVUDINA (Comp.Revest.)[600 + 300 MG COMP]
TED · 761892-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 35 | — | 2026-10-27 |
| GILEAD SCIENCES, LDA | 32 | — | 2026-11-03 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 25 | €1,569,649 | 2026-11-03 |
| JANSSEN-CILAG FARMACEUTICA LDA | 19 | €371,730 | 2026-10-13 |
| NOVARTIS FARMA - PROD.FARM SA | 19 | — | 2026-10-20 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
ABACAVIR + LAMIVUDINA (Comp.Revest.)[600 + 300 MG COMP]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-11-03 | A729 - ABACAVIR + LAMIVUDINA (Comp.Revest.)[600 + 300 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-07-07 | 2024/0900 - DOLUTEGRAVIR + ABACAVIR + LAMIVUDINA [50 MG + 600 MG + 300 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-07-28 | 2024/0900 - LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-10-27 | L1061 - LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-07-28 | 2024/0900 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-09-08 | 2024/0900 - DARUNAVIR + COBICISTATE [800 MG + 150 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |